Factors associated with medication-related problems in ambulatory hemodialysis patients

American Journal of Kidney Diseases

Volumn 41, Issue 2, 2003, Pages 386-393

  Manley, Harold J ^a,b,c,d   McClaran, Marcy L ^a,b,c,d   Overbay, Debra K ^a,b,c,d   Wright, Marcia A ^a,b,c,d   Reid, Gerald M ^a,b,c,d   Bender, Walter L ^a,b,c,d   Neufeld, Timothy K ^a,b,c,d   Hebbar, Sudarshan ^a,b,c,d   Muther, Richard S ^a,b,c,d  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Dialysis Clinic Incorporated   (United States)

^c PFIZER INC   (United States)

^d Infectious Disease Associates of Kansas City   (United States)

Author keywords

Hemodialysis (HD); Medication related problem; Risk factor

Indexed keywords

ADULT; AGED; AMBULATORY CARE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; ERROR; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT;

EID: 0037311037     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50048     Document Type: Article

References (26)

1. Nelson KM, Talbert RL: Drug-related hospital admissions. Pharmacotherapy 16:701-707, 1996
2. Ebbesen J, Buajordet I, Erikssen J, et al: Drug-related deaths in a department of internal medicine. Arch Intern Med 161:2317-2323, 2001
3. Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279:1200-1205, 1998
4. Ernst FR, Grizzle AJ: Drug-related morbidity and mortality: Updating the cost-of-illness model. J Am Pharm Assoc (Wash) 41:192-199, 2001
5. Kohn LT, Corrigan JM, Donaldson MS (ed): To Err Is Human: Building a Safer Health System. Washington, DC, National Academy, 1999
6. Strand LM, Morley PC, Cipolle RJ: Drug-related problems: Their structure and function. DICP 24:1093-1097, 1990
7. Koecheler JA, Abramowitz PW, Swim SE, Daniels CE: Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 46:729-732, 1989
8. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL: Preventable adverse drug events in hospitalized patients: A comparative study of intensive care units and general care units. Crit Care Med 25:1289-1297, 1997
9. US Renal Data System: USRDS 2001 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2001
10. US Renal Data Systems: USRDS 1999 Annual Data Report. The National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases, Bethesda, MD, 1999
11. US Renal Data Systems: USRDS 1998 Annual Data Report. The National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases, Bethesda, MD, 1998
12. Grabe DW, Low CL, Bailie GR, et al: Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 47:117-121, 1997
13. Kaplan B, Mason NA, Shimp LA, et al: Chronic hemodialysis patients. Part I: Characterization and drug-related problems. Ann Pharmacother 28:316-319, 1994
14. Kaplan B, Shimp LA, Mason NA, et al: Chronic hemodialysis patients. Part II: Reducing drug-related problems through application of the focused drug therapy review program. Ann Pharmacother 28:320-324, 1994
15. Stoutakis VA, Acchiardo SR, Martinez DR, Lorisch D, Wood GC: Role-effectiveness of the pharmacist in the treatment of hemodialysis patients. Am J Hosp Pharm 35:62-65, 1978
16. Tang I, Vrahnos D, Hatoum H, et al: Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther 15:459-464, 1993
17. Bleyer AJ, Hylander B, Sudo H, et al: An international study of patient compliance with hemodialysis. JAMA 281:1211-1213, 1999
18. Long JM, Kee CC, Graham MV, Saethang TB, Dames FD: Medication compliance and the older hemodialysis patient. ANNA J 25:43-49, 1998
19. Curtin RB, Svarstad BL, Keller TH: Hemodialysis patients' noncompliance with oral medications. ANNA J 26:307-316, 1999
20. Bander SJ, Walters BA: Hemodialysis morbidity and mortality: Links to patient non-compliance. Curr Opin Nephrol Hypertens 7:649-653, 1998
21. Leggat JE, Orzol SM, Hulbert-Shearon TE, et al: Noncompliance in hemodialysis: Predictors and survival analysis. Am J Kidney Dis 32:139-145, 1998
22. Manley HJ, Bailie GR, Grabe DW: National database information: Utility for an individual hemodialysis center. Am J Health Syst Pharm 57:902-906, 2000
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
24. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ: Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic renal disease. Am Heart J 144:226-232, 2002
25. Tozawa M, Iseki K, Iseki C, et al: Analysis of drug prescription and survival in patients on chronic hemodialysis. J Am Soc Nephrol 12:349A, 2001 (abstr A1795)
26. Manley HJ, Carroll C: The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Semin Dial 15:45-49, 2002